RNA-based Therapeutics
Shape Therapeutics RNAfix® Editing Platform Achieves >90% Editing in Mouse and Non-Human Primate Brain
Buy Recommendation on ProQR’s Innovative RNA Editing Platform and Promising Clinical Prospects
Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress
Scientists reveal how SID-1 recognizes dsRNA and initiates systemic RNA interference
Alnylam Pharmaceuticals
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer(TM) RNA Editing Program Targeting NTCP for Cholestatic Diseases
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024
RNA Nanotechnology
RNA's hidden potential: New study unveils its role in early life and future bioengineering
A promising target for new RNA therapeutics now accessible
Nanotechnology News
RNA News and Research
Improving Gene Therapy for Lung Disease
Long-Lived RNA in Nerve Cells Can Last a Lifetime
About the Editors
Avidity Biosciences Stock (NASDAQ:RNA), Quotes and News Summary
Nano Hearing Aids Review 2024: Read Before Buying
RNA Vaccines
New mRNA Vaccines in Development for Cancer and Infections
mRNA vaccine tackles deadly brain cancer in human trial
RNA
RNA blood test may predict antidepressant response
Google DeepMind Develops Latest AI Model To Aid Scientists In Fighting Disease